ScreenerHero

COR Cencora, Inc. Common Stock

NYSE · US · Real Estate · Medical Distribution · cencora.com
314.82USD+1.87%Mkt Cap: 58.98B $P/E: 22.93

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter…

Industry Peers

Medical Distribution
Screen all
MCK
McKesson Corporation Common Stock
$105.20BUSDP/E 24.2
CAH
Cardinal Health, Inc. Common Stock
$52.86BUSDP/E 31.6
HSIC
Henry Schein, Inc. - Common Stock
$9.67BUSDP/E 24.7
GALE
Galenica AG
$4.68BUSDP/E 25.5
AMP
Amplifon S.p.A.
$3.49BUSDP/E 39.0
ASKER
Asker Healthcare Group AB (publ)
$2.45BUSDP/E 37.6
UPR
Uniphar plc
$1.12BUSDP/E 18.9
AHG
Akso Health Group - American Depositary Shares
$985.21MUSD
SELEC
Selcuk Ecza Deposu Ticaret ve Sanayi A.S.
$1.11BUSDP/E 21.0
NEU
NEUCA S.A.
$808.69MUSDP/E 16.5
ARJO-B
Arjo AB (publ)
$694.57MUSDP/E 18.8
M12
M1 Kliniken AG
$411.44MUSDP/E 20.0
ILM1
Medios AG
$285.55MUSDP/E 22.4
FOCL
EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share
$198.31MUSD
BLC
Bastide Le Confort Médical SA
$150.95MUSDP/E 20.7
MLFMV
Farminveste, S.G.P.S., S.A.
$81.65MUSD
ACH
Accendra Health, Inc. Common Stock
$38.85MUSD
COSM
Cosmos Health Inc. - Common Stock
$38.24MUSD
NAVA
Navamedic ASA
$29.25MUSD
YI
111, Inc. - American Depositary Shares
$28.33MUSD

Key Statistics

Company
Market Cap58.98B USD
Enterprise Value70.81B USD
Revenue (TTM)332.77B USD
Gross Profit11.48B USD
Net Income (TTM)1.55B USD
Revenue/Share1715.73 USD
Last Price314.82 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees47.0K
CountryUS
SectorReal Estate
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)22.93
P/E (Forward)15.59
PEG0.65
EV/EBITDA12.77
EV/Revenue0.21
P/S0.18
P/B19.33
EPS (TTM)13.47
EPS (Forward)19.83
52W Range
244.8253% of range377.54
52W High377.54 USD
52W Low244.82 USD
Profitability
Gross Margin3.57%
Oper. Margin1.41%
EBITDA Margin1.67%
Profit Margin0.48%
ROE103.06%
ROA2.03%
Growth
Revenue Growth5.10%
Earnings Growth11.90%
Cash Flow & Leverage
Operating CF3.88B USD
CapEx (TTM)667.98M USD
FCF Margin0.61%
FCF Yield3.46%
Net Debt11.65B USD
Net Debt/EBITDA2.10
Balance Sheet
Debt/Equity5.08
Current Ratio0.94
Quick Ratio0.48
Book Value/Sh15.99 USD
Cash/Share14.75 USD
Dividends
Fwd Div Rate2.40 USD
Trail. Div Rate2.35 USD
Div. Yield0.78%
5Y Avg Yield0.92%
Payout Ratio17.45%
Ex-Div DateAug 14, 2026
Pay DateAug 31, 2026
Splits
Last Split2:1
Split DateJun 16, 2009
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)369.25 USD
Upside (mean)+17.3%
Target Range330.00 USD – 430.00 USD
330.00+17.3% to mean430.00
# Analysts12
Ownership
Shares Out.190.83M
Float180.25M
Insiders4.30%
Institutions99.63%
Short Interest
Short Ratio3.8d
Short % Float2.57%
Short % Out.2.26%
Shares Short4.31M
Short (prev mo.)4.64M
Technical
SMA 50317.69 (-0.9%)
SMA 200318.19 (-1.1%)
Beta0.57
S&P 52W Chg14.58%
Avg Vol (30d)1.20M
Avg Vol (10d)1.27M
Technical Indicators
RSI (14)45.6
MACD-3.5798
MACD Signal-2.4702
MACD Hist.-1.1096
BB Upper331.67 USD
BB Middle314.91 USD
BB Lower298.15 USD
BB Width10.65%
ATR (14)8.189 USD
Vol Ratio (20d)0.90x